ZNTL is currently covered by 7 analysts with average potential upside of $19.33 (44.62%) backed by 12 price targets and 33 ratings. Documented since 28-Apr-2020. Analyst's average stock valuation to be materialised ratio is 44.58% with an average time for price targets to be met of 78.5 days.
Most recent stock forecast was given by ANDREW FEIN from HCWAINWRIGHT on 02-Mar-2023.
Highest price target for ZNTL is 80, Lowest price target is 19, average price target is 49.5.
Currently, out of the existing stock ratings of ZNTL - 22 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
55
$37.85 (220.70%)
55
23 days ago
2/5 (40%)
$27.33 (78.61%)
123
Buy
32
$14.85 (86.59%)
89
4 months 11 days ago
1/3 (33.33%)
$13.04 (31.52%)
222
Buy
28
$10.85 (63.27%)
45
4 months 14 days ago
1/2 (50%)
$7.84 (27.60%)
31
Buy
42
$24.85 (144.90%)
97
7 months 15 days ago
3/6 (50%)
$12.99 (25.78%)
58
Buy
74
$56.85 (331.49%)
94
11 months 14 days ago
1/3 (33.33%)
$31.67 (74.16%)
33
What is ZNTL(Zentalis Pharmaceuticals Inc) average time for price targets to be met?
Which analyst has the current highest performing score on ZNTL(Zentalis Pharmaceuticals Inc) with a proven track record?
